
Scientists at Texas A&M University have developed a new type of industrial hemp plant that produces no detectable THC, CBD, or other tested cannabinoids, potentially eliminating one of the most expensive regulatory risks facing American hemp farmers. Announced November 19, 2026, by Texas A&M AgriLife Research, the discovery involves a patent-pending genetic trait that prevents the development of the glandular structures responsible for cannabinoid production. Laboratory analysis of the experimental plants detected none of the 18 cannabinoids examined, marking a significant achievement in efforts to develop hemp varieties specifically suited for fiber, grain, and other industrial applications.
The breakthrough could reshape how industrial hemp is cultivated in the United States and internationally, particularly in regions where strict THC regulations have discouraged agricultural investment. Unlike conventional hemp varieties that produce small amounts of THC and CBD, the newly developed plants belong to a cannabinoid-deficient category known as Type V cannabis. Researchers believe incorporating this trait into commercially productive hemp varieties could allow farmers to grow the crop without constantly worrying that naturally occurring THC levels might exceed legal thresholds. However, the plants remain in development, with field trials planned for 2027 and 2028 and potential commercial seed availability anticipated by 2029.
Texas A&M Researchers Discover a New Approach to Cannabinoid-Free Hemp
The research was conducted through a collaboration between Texas A&M AgriLife Research and Rare Earth Genomics Texas LLC, a biotechnology company based in Bryan–College Station. The project was directed by Russell Jessup, a professor in the Department of Soil and Crop Sciences and director of the Texas A&M AgriLife Research and Extension Center in San Angelo. Jessup established the university’s industrial hemp breeding program in 2020, shortly after Texas began permitting regulated hemp cultivation. His team has focused on developing varieties capable of performing under regional growing conditions while addressing the regulatory and agricultural challenges that have limited domestic production.
A central figure in the discovery is Teja Sri Vengala, who joined the research program as a master’s student in 2022 and began investigating hemp trichomes the following year. After completing her degree in 2024, she continued the work as lead plant scientist at Rare Earth Genomics. Rather than relying on conventional low-THC breeding or directly editing cannabinoid-producing genes, Vengala investigated whether the plant’s cannabinoid production structures could be altered. The resulting discovery identified plants that developed trichomes without their typical glandular heads, effectively disrupting the structures where cannabinoids normally accumulate.
Scientists Target Trichomes Instead of THC-Producing Genes
Cannabis plants produce many of their characteristic chemical compounds within specialized structures called glandular trichomes. These tiny, hairlike formations are especially abundant on female cannabis flowers and commonly contain resin-producing glands. Inside these glands, specialized cells synthesize and accumulate cannabinoids, including THC, CBD, and various minor compounds. In conventional cannabis breeding, researchers frequently focus on genes associated with cannabinoid synthesis, attempting to influence the proportions of THC, CBD, or other metabolites produced by the plant. The Texas A&M team approached the problem differently by targeting the development of the glands themselves.
Vengala used a technique known as chemical mutation breeding, exposing hemp seeds to carefully controlled treatments of ethyl methanesulfonate, or EMS, to generate genetic variation. She then examined thousands of resulting plants for unusual physical characteristics, eventually identifying individuals whose trichomes lacked normal glandular heads. The technique does not involve inserting foreign DNA or directly editing specific genes using technologies such as CRISPR. Instead, chemical mutagens introduce genetic changes that breeders can identify and select across subsequent generations. Although the method is distinct from genetic engineering, it still deliberately induces mutations. By selecting plants with the desired glandless characteristic, researchers developed a new pathway toward hemp that does not accumulate detectable cannabinoids.
Laboratory Testing Finds No Detectable THC, CBD or Other Cannabinoids
After identifying promising plants, researchers used self-pollination to produce additional generations and investigate whether the unusual trait could be maintained. Laboratory analysis was then conducted using high-performance liquid chromatography, a widely used analytical technique for separating and measuring chemical compounds in cannabis material. The researchers screened for 18 cannabinoids and reported that none were detected. The findings included the absence of detectable THC and CBD, two of the most commercially significant cannabis compounds. Because the plant lacked the glandular structures responsible for cannabinoid accumulation, the results supported the team’s hypothesis that disrupting trichome development could provide an alternative route to cannabinoid-deficient hemp.
An important scientific distinction is that a laboratory result showing no detectable cannabinoids does not necessarily establish that every molecule of THC or CBD has been eliminated. Detection depends on the analytical method, the sample examined, and the concentrations that the equipment can reliably identify. Nevertheless, the reported findings are substantially different from those associated with ordinary low-THC industrial hemp, which may contain measurable quantities of cannabinoids while remaining legally compliant. The breeding research was supported by work published in August 2026 in the journal Crops, titled Determination of the EMS Lethal Dose (LD50) and Characterization of Induced Mutations in Industrial Hemp (Cannabis sativa L.). That paper details the mutation-breeding methodology, while the specific cannabinoid-free trait and its analytical results were described in the university’s November announcement.
Why THC Contamination Is a Major Problem for Hemp Farmers
Industrial hemp cultivation has historically faced a fundamental regulatory challenge: even varieties grown exclusively for stalks, fiber, or seeds can produce enough THC to exceed legal limits. Under the federal hemp production framework, crops are generally evaluated against a threshold of 0.3% total THC on a dry-weight basis, accounting for the potential conversion of THCA into THC. Plants exceeding the permitted concentration may be classified as noncompliant, requiring farmers to dispose of affected material according to applicable regulations. This creates financial uncertainty because growers can invest months of labor, land, irrigation, fertilizer, and equipment into crops that ultimately cannot be harvested for commercial use.
The problem is particularly significant in regions where existing hemp genetics are poorly adapted to local environmental conditions. Jessup reported that nearly every imported Asian fiber hemp variety tested in Texas during 2023 exceeded the federal THC threshold, despite some of those varieties being among the better-performing fiber types under Texas growing conditions. Cultivar genetics, maturity, and growing conditions can all influence cannabinoid concentrations, creating challenges for producers attempting to balance agricultural performance with regulatory compliance. A stable Type V hemp variety could dramatically reduce the risk of THC-related crop failure. However, farmers would still need to follow applicable licensing, sampling, and testing requirements unless regulators specifically modify those obligations.
Type V Hemp Could Transform Industrial Fiber Production
One of the most promising commercial applications involves hemp fiber, which is used in textiles, paper, insulation, composite materials, and various industrial products. Hemp stalks contain two principal categories of usable material: bast fibers located along the outer portion of the stem and the woody inner core commonly called hurd or shiv. Bast fibers can be processed into textiles, ropes, and reinforcement materials, while the inner core is used in animal bedding, construction products, and hemp-lime building materials commonly known as hempcrete. None of these applications depends on meaningful THC or CBD production, making cannabinoid-deficient varieties potentially attractive to farmers supplying industrial processors.
For the fiber industry, reliable compliance could become nearly as important as yield, stalk quality, or harvest efficiency. Industrial hemp producers frequently operate under commodity-style economic conditions where profit margins depend on predictable harvests and processing contracts. Losing an entire crop because THC concentrations exceed a regulatory threshold introduces a risk that conventional grain and fiber growers do not face in the same way. If the new trait can be incorporated into tall, productive hemp cultivars without compromising fiber strength or biomass production, it could make industrial hemp more practical for large-scale agricultural operations. Commercial success will still depend on processing infrastructure, transportation costs, market demand, and competition from established materials such as cotton, flax, wood fiber, and synthetic alternatives.
Cannabinoid-Free Hemp Could Expand Grain and Seed Markets
The discovery also has potential implications for hemp grain production, an agricultural sector centered on harvesting seeds rather than cannabinoid-rich flowers. Hemp seeds are valued for their protein content, essential fatty acids, and applications in food products, oils, and animal feed ingredients. They contain substantial amounts of omega-3 and omega-6 fatty acids, making them useful in nutritional formulations and potentially valuable in livestock and poultry feeding programs where regulations permit their use. Texas A&M researchers are particularly interested in developing grain cultivars adapted to the state’s growing conditions, as existing varieties originating from Canada and Europe have not consistently provided the characteristics required for successful regional production.
A cannabinoid-deficient grain crop could provide agricultural advantages by reducing the risk that flowering plants will develop excessive THC before seed maturity. Hemp grown for grain must remain in the field long enough to develop harvestable seeds, potentially creating conflicts between optimum agricultural timing and cannabinoid compliance. The Texas A&M team believes its new trait could help separate these concerns, allowing breeders to select for seed yield, maturation characteristics, and regional adaptability without relying exclusively on low-THC genetics. However, the absence of detectable cannabinoids does not automatically establish that the experimental plants will produce competitive grain yields or meet commercial quality standards. Those questions will require further breeding and field evaluation.
The Discovery Does Not Benefit Every Segment of the Hemp Industry
While cannabinoid-free hemp could be valuable for industrial agriculture, it is unlikely to replace cultivars developed for CBD extraction or other cannabinoid-based products. Hemp grown for CBD depends on the plant’s ability to produce substantial concentrations of cannabinoids, often within abundant glandular trichomes. Manufacturers use these compounds to produce extracts, topical products, wellness formulations, and other cannabinoid-containing goods. A plant that cannot accumulate detectable CBD would offer little direct value to businesses whose revenue depends on cannabinoid extraction. Consequently, the Texas A&M discovery is better understood as a specialized agricultural development than as a universal replacement for existing hemp genetics.
The distinction highlights how cannabis breeding is becoming increasingly specialized. Medical marijuana breeders often prioritize cannabinoid profiles, terpene characteristics, potency, and therapeutic research applications, while industrial hemp breeders may focus on stalk height, fiber quality, seed production, regional adaptation, and harvesting efficiency. The new Type V trait demonstrates that the plant can potentially be developed for industrial purposes without retaining the chemical characteristics commonly associated with cannabis consumption. Rather than weakening the broader cannabis industry, separate breeding pathways could help establish clearer distinctions between hemp cultivated as an agricultural commodity and cannabis produced for cannabinoid-rich consumer or medical applications.
Researchers Identify Two Candidate Genes Behind the Unusual Trait
Beyond the immediate agricultural implications, the discovery provides an opportunity to better understand the genetic mechanisms governing trichome development. Following the identification of glandless plants, Vengala conducted whole-genome sequencing and sequence comparisons to investigate the underlying genetic changes. The analysis identified two candidate genes potentially associated with the unusual trichome characteristics. Researchers are now working with the Texas A&M AgriLife Genomics and Bioinformatics Service to validate those candidates and develop molecular markers capable of identifying plants carrying the desired trait. These tools could eventually allow breeders to screen seedlings for relevant genetic characteristics without waiting for plants to mature.
The genetic investigation remains important because the relationship between glandular trichomes, plant development, and chemical production is complex. Trichomes can participate in plant defense and environmental interactions, and some glandular structures produce compounds besides cannabinoids. Researchers will need to determine whether eliminating the glands changes other aspects of plant biology, including pest resistance, plant vigor, reproductive development, or chemical composition. The two candidate genes have not yet been established as the definitive cause of the observed phenotype. Understanding their functions could make it easier to introduce the trait into diverse hemp backgrounds while avoiding unwanted characteristics introduced during mutation breeding.
Patent-Pending Technology Attracts International Interest
Texas A&M AgriLife Research reports that the new trait is patent pending and has been exclusively licensed to Rare Earth Genomics Texas. The arrangement gives the technology a defined commercial development pathway while researchers continue investigating its genetic basis and agricultural applications. According to Jessup, companies and government organizations in multiple countries have already expressed interest in the discovery. The researchers envision breeders introducing the Type V characteristic into locally adapted hemp populations, creating specialized cultivars for different climates and production goals. However, access to the patented technology would remain subject to applicable licensing arrangements.
International demand could become particularly significant because hemp regulations differ considerably across national markets. Some countries impose stricter THC limits than the United States, while others maintain restrictions that complicate the movement of hemp seed and agricultural products. Reliable cannabinoid-deficient genetics could help producers address those requirements while developing varieties for fiber and grain markets. Nevertheless, legal treatment would depend on each jurisdiction’s rules regarding hemp cultivation, seed certification, plant genetics, and chemical testing. The discovery may support international agricultural expansion, but it does not automatically eliminate regulatory obligations or guarantee approval for cultivation in every country.
Field Trials Will Determine Whether the Hemp Breakthrough Is Commercially Viable
The research team plans to increase seed production during the winter of 2026–2027 before conducting field trials in 2027 and 2028. Those trials will be essential for determining whether the cannabinoid-deficient trait remains consistent across growing environments and successive generations. They will also allow scientists to evaluate commercially important characteristics, including plant height, biomass production, fiber quality, seed yield, and overall agricultural performance. A hemp variety that remains consistently below detectable cannabinoid levels but produces poor harvests would offer limited commercial value. Successful development will therefore require combining the new trait with genetics capable of meeting the practical requirements of farmers and processors.
Jessup anticipates that seed from Texas A&M-developed hemp cultivars incorporating the Type V characteristic could become available to commercial producers by 2029, although that timeline remains dependent on breeding progress and field results. The broader significance of the discovery extends beyond removing cannabinoids from a single experimental plant. It demonstrates how targeted breeding can address a regulatory problem that has discouraged investment in industrial hemp agriculture. If researchers can establish durable cannabinoid deficiency without sacrificing productivity, the technology could help transform hemp from a crop burdened by chemical compliance uncertainty into a more predictable source of renewable fiber, grain, and industrial raw materials. For now, the achievement represents a promising scientific advance whose full commercial impact remains to be demonstrated.






